Correlation Between Nuvalent and Tscan Therapeutics
Can any of the company-specific risk be diversified away by investing in both Nuvalent and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvalent and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvalent and Tscan Therapeutics, you can compare the effects of market volatilities on Nuvalent and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvalent with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvalent and Tscan Therapeutics.
Diversification Opportunities for Nuvalent and Tscan Therapeutics
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between Nuvalent and Tscan is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Nuvalent and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and Nuvalent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvalent are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of Nuvalent i.e., Nuvalent and Tscan Therapeutics go up and down completely randomly.
Pair Corralation between Nuvalent and Tscan Therapeutics
Given the investment horizon of 90 days Nuvalent is expected to generate 0.38 times more return on investment than Tscan Therapeutics. However, Nuvalent is 2.62 times less risky than Tscan Therapeutics. It trades about 0.22 of its potential returns per unit of risk. Tscan Therapeutics is currently generating about -0.01 per unit of risk. If you would invest 8,922 in Nuvalent on September 2, 2024 and sell it today you would earn a total of 746.00 from holding Nuvalent or generate 8.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nuvalent vs. Tscan Therapeutics
Performance |
| Timeline |
| Nuvalent |
| Tscan Therapeutics |
Nuvalent and Tscan Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nuvalent and Tscan Therapeutics
The main advantage of trading using opposite Nuvalent and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvalent position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.| Nuvalent vs. Arcellx | Nuvalent vs. Vaxcyte | Nuvalent vs. Viridian Therapeutics | Nuvalent vs. Ventyx Biosciences |
| Tscan Therapeutics vs. Tff Pharmaceuticals | Tscan Therapeutics vs. Eliem Therapeutics | Tscan Therapeutics vs. Inhibrx | Tscan Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |